Deutsche Märkte geschlossen

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
357,48+3,07 (+0,87%)
Börsenschluss: 04:00PM EDT
357,50 +0,02 (+0,01%)
Nachbörse: 05:22PM EDT

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-1147
United States
610 594 2900
https://www.westpharma.com

Sektor(en)Healthcare
BrancheMedical Instruments & Supplies
Vollzeitmitarbeiter10.600

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO2,9M45,4M1970
Mr. Bernard J. BirkettSenior VP and Chief Financial & Operations Officer1,39M6M1969
Mr. Silji AbrahamSenior VP & CTO972,09k4,64M1972
Ms. Kimberly Banks MacKaySenior VP, General Counsel & Company Secretary841,52kN/A1966
Ms. Cindy Reiss-ClarkSenior VP & Chief Commercial Officer879,48k452,64k1974
Mr. Chad R. WintersVP, Chief Accounting Officer & Corporate ControllerN/AN/A1979
Michele PolinskyVice President of Global CommunicationsN/AN/AN/A
Mr. Rudy PoussotSenior VP of Strategy & Corporate DevelopmentN/AN/AN/A
Ms. Annette F. FavoriteChief Human Resources Officer & Senior VP803,25kN/A1965
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Corporate Governance

West Pharmaceutical Services, Inc.s ISS Governance QualityScore, Stand 29. April 2024, lautet 6. Die grundlegenden Scores sind Audit: 3, Vorstand: 8, Shareholderrechte: 8, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.